1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1)
- Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer : Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial
- 2017
- Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma
- Vaccination and allergy : EAACI position paper, practical aspects
- 2016
- Regulation of the germinal center response by T follicular helper cells and type I interferons
- 2015
-
Tamoxifen treated patients have a better survival than patients treated with aromatase inhibitors - A population based registry study in Sweden
H., Olsson LU
; Einefors, R
and P., Broberg
LU
(2015)
37th San Antonio Breast Cancer Symposium
In Cancer Research
75(9 Suppl).
Mark
- 2012
-
Adjuvant therapy in primary GIST: state-of-the-art
Reichardt, P. ; Blay, J. -Y. ; Boukovinas, I. ; Brodowicz, T. ; Broto, J. M. ; Casali, P. G. ; Decatris, M. ; Eriksson, Mikael LU
; Gelderblom, H.
and Kosmidis, P.
, et al.
(2012)
In Annals of Oncology
23(11).
p.2776-2781
Mark
- 2008
-
Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer.
Dihge, Looket ; Bendahl, Pär-Ola LU ; Grabau, Dorthe LU ; Isola, Jorma ; Lövgren, Kristina LU ; Rydén, Lisa LU
and Fernö, Mårten
LU
(2008)
In Breast Cancer Research and Treatment
109(2).
p.255-262
Mark
- 2007
- Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy
- 2006
- Abdominal & pelvic radiotherapy: acute effects on inflammation, leucocytes and collagen deposition